GW Pharmaceuticals Beats CBD Patent Infringement Suit

By Sarah Jarvis ( March 1, 2022, 3:10 PM EST) -- A Texas federal judge has tossed Canopy Growth Corp.'s claims against GW Pharmaceuticals PLC units for allegedly infringing its patented extraction process to make the flagship CBD drug Epidiolex, after the parties agreed that Canopy couldn't prevail on the issue of infringement....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!